A cAMP-dependent reporter gene has been used in transiently transfecte
d human choriocarcinoma (JEG-3) cells to examine the second messenger
coupling of the human alpha2-adrenergic receptor subtypes. The reporte
r gene consists of a cAMP response element linked to the gene for chlo
ramphenicol acetyltransferase (CAT). Plasmids encoding the alpha2-C10
(alpha2A), alpha2-C2 (alpha2B), or alpha2-C4 (alpha2C) receptor subtyp
es were co-transfected with a plasmid containing the reporter gene, an
d the ability of alpha2 receptor agonists to influence forskolin-stimu
lated CAT expression was examined. For alpha2-C10, agonists had a biph
asic effect on forskolin-stimulated CAT expression. Thus, low (nanomol
ar) concentrations of agonist inhibited CAT expression by approximatel
y 60%, whereas high (micromolar) concentrations reversed this inhibiti
on and could even potentiate CAT expression by as much as 140%. A sign
ificantly different pattern of coupling was observed for the other alp
ha2 receptor subtypes. For alpha2-C4, agonists only inhibited forskoli
n-stimulated CAT expression, whereas for alpha2-C2 only potentiation o
f expression was seen. Each of these responses was specifically blocke
d by alpha2- but not alpha1- or beta-adrenergic receptor antagonists.
For alpha2-C4, the inhibition of forskolin-stimulated CAT expression w
as prevented by pretreatment of the cells with pertussis toxin. This w
as also true for the inhibition obtained with alpha2-C10. The potentia
tion of CAT expression, however, was not prevented by pertussis toxin
pretreatment in cells transfected with either alpha2-C2 or alpha2-C10.
In this transient expression system, each alpha2-adrenergic receptor
subtype had access to the same complement of G proteins, adenylyl cycl
ase, and other second messengers. It would appear, therefore, that the
potential for the activation of unique intracellular responses exists
even among closely related receptor subtypes.